Literature DB >> 24065199

Tumor cell uptake of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in comparison with 2-deoxy-2-[18F]fluoro-D-glucose in vitro: kinetics, dependencies, blockage and cell compartment of accumulation.

M Seidensticker1, G Ulrich, F L Muehlberg, A Pethe, O S Grosser, I G Steffen, M Stiebler, J Goldschmidt, K H Smalla, R Seidensticker, J Ricke, H Amthauer, K Mohnike.   

Abstract

PURPOSE: This study was conducted to investigate the capacity of (99m)Tc-labeled 1-thio-β-D-glucose ((99m)Tc-1-TG) and 5-thio-D-glucose ((99m)Tc-5-TG) to act as a marker for glucose metabolism in tumor cells in vitro. PROCEDURES: We investigated the cellular uptake of (99m)Tc-1-TG, (99m)Tc-5-TG, and 2-deoxy-2-[(18)F]fluoro-D-glucose((18)F-FDG) in a human colorectal carcinoma and human lung adenocarcinoma cell line (HCT-116, A549) at different time points and varying glucose/insulin concentrations and under transporter blockage by cytochalasin-B and phloretin. Cell compartment analysis was performed.
RESULTS: A significant uptake and time dependency thereof, a significant uptake dependency on glucose and insulin and a significant uptake inhibition by cytochalasin-B for (99m)Tc-1-TG and (99m)Tc-5-TG, was shown. Albeit substantial, the uptake was less pronounced in (99m)Tc-1-TG and (99m)Tc-5-TG compared with (18)F-FDG. (99m)Tc-1-TG and (99m)Tc-5-TG showed a higher accumulation in the cell membranes compared with (18)F-FDG.
CONCLUSION: Tc-1-TG and (99m)Tc-5-TG showed an uptake in vitro with glucose analog characteristics but with membranous accumulation. Tumor imaging should be investigated in an animal model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24065199     DOI: 10.1007/s11307-013-0690-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  46 in total

1.  Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells.

Authors:  I Lisinski; A Schürmann; H G Joost; S W Cushman; H Al-Hasani
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction.

Authors:  T Suzuki; A Iwazaki; H Katagiri; Y Oka; J L Redpath; E J Stanbridge; T Kitagawa
Journal:  Eur J Biochem       Date:  1999-06

3.  The atachment of phloretin and analogues to human erythrocytes in connection with inhibition of sugar transport.

Authors:  P G LEFEVRE; J K MARSHALL
Journal:  J Biol Chem       Date:  1959-11       Impact factor: 5.157

4.  Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

Authors:  R S Brown; J Y Leung; P V Kison; K R Zasadny; A Flint; R L Wahl
Journal:  J Nucl Med       Date:  1999-04       Impact factor: 10.057

Review 5.  The glucose transporter family: structure, function and tissue-specific expression.

Authors:  G W Gould; G D Holman
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

Review 6.  Molecular physiology of sodium-glucose cotransporters.

Authors:  M A Hediger; D B Rhoads
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

7.  99mTc-labeled 1-thio-beta-D-glucose as a new tumor-seeking agent: synthesis and tumor cell uptake assay.

Authors:  Seung Jun Oh; Jin-Sook Ryu; Eun-Jin Yoon; Mun Sun Bae; Sun Joo Choi; Kyung Bae Park; Dae Hyuk Moon
Journal:  Appl Radiat Isot       Date:  2005-09-15       Impact factor: 1.513

Review 8.  The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.

Authors:  Kyle E Rusthoven; Mary Koshy; Arnold C Paulino
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

Review 9.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

10.  Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors.

Authors:  D A Basketter; W F Widdas
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

View more
  1 in total

1.  Phase I Clinical Trial Using [99mTc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients.

Authors:  Vladimir Chernov; Ekaterina Dudnikova; Roman Zelchan; Anna Medvedeva; Anstasiya Rybina; Olga Bragina; Viktor Goldberg; Albina Muravleva; Jens Sörensen; Vladimir Tolmachev
Journal:  Pharmaceutics       Date:  2022-06-15       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.